ESC Premium Access

Atrial fibrillation: risks and management

Event: ESC Congress 2021 - The Digital Experience
Topic: Atrial Fibrillation (AF)
Session type: Abstract Sessions
Date: 28 August 2021
Time: 07:15 - 08:00

Congress Session

5 presentations in this session

Risk of dementia according to smoking cessation after newly diagnosed atrial fibrillation: a nationwide cohort study

Speaker: Doctor H. Lee (Seoul, KR)
Thumbnail

Beta-blocker treatment in atrial fibrillation with chronic obstructive pulmonary disease: a Danish nationwide study from 1995 to 2015

Speaker: Mr C. Benson (Copenhagen, DK)
Thumbnail

Lower risk of stroke after alcohol abstinence in patients with incident atrial fibrillation: a nationwide population-based cohort study

Speaker: Doctor S. Lee (Seoul, KR)
Thumbnail

Chronic kidney disease and risk of atrial fibrillation and heart failure in general population-based cohorts - the BiomarCaRE project.

Speaker: Professor D. Rothenbacher (Ulm, DE)
Thumbnail

Comparative effectiveness and safety of edoxaban vs warfarin in patients with atrial fibrillation: a nationwide cohort study

Speaker: Mr P. Nielsen (Aalborg, DK)
Thumbnail

5 speakers from this session

Doctor Huijin Lee

Seoul National University, Seoul (Korea (Republic of))
0 follower

Mr Christan Suppli Benson

Herlev and Gentofte Hospital, Copenhagen (Denmark)
0 follower

Doctor So-Ryoung Lee

Seoul National University Hospital, Seoul (Korea (Republic of))
0 follower

Professor Dietrich Rothenbacher

, Ulm (Germany)
0 follower

Mr Peter Bronnum Nielsen

Aalborg University Hospital, Aalborg (Denmark)
2 presentations
0 follower

This platform is supported by

logo Novo Nordisk